Evidence map›Paper›PMID 39958836›Full record

ArticleBiomedical optics express2025

Development of a label-free, functional, molecular and structural imaging system combining optical coherence tomography and Raman spectroscopy for in vivo measurement of rat retina.

Ryan Sentosa, Matthias Salas, Conrad W Merkle, Matthias Eibl, Wim de Jong, Arjen Amelink, Michael Schmitt, Igor Krestnikov, Vasyl Shynkar, Michael Kempe and 7 more

Abstract read
In one paragraph

Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ryan SentosaCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-2060-7905
Matthias SalasCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.
Conrad W MerkleCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-2465-4100
Matthias EiblCarl Zeiss AG, 07745 Jena, Thuringia, Germany.
Wim de JongTNO, Optics Department, 2628 CK Delft, Netherlands.
Arjen AmelinkTNO, Optics Department, 2628 CK Delft, Netherlands.ORCID https://orcid.org/0009-0003-0374-4224
Michael SchmittInstitute of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, 07745 Jena, Thuringia, Germany.ORCID https://orcid.org/0000-0002-3807-3630
Igor KrestnikovInnolume GmbH, 44263 Dortmund, Nordrhein-Westfalen, Germany.
Vasyl ShynkarHORIBA France SAS, 59120 LOOS, France.ORCID https://orcid.org/0000-0003-2825-0573
Michael KempeCarl Zeiss AG, 07745 Jena, Thuringia, Germany.
Tilman SchmollCarl Zeiss Meditec, Inc., Dublin, CA 94568, USA.
Bernhard BaumannCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-6419-1932
Marco AndreanaCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-8212-0545
Angelika UnterhuberCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-1251-3001
Jürgen PoppInstitute of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, 07745 Jena, Thuringia, Germany.ORCID https://orcid.org/0000-0003-4257-593X
Wolfgang DrexlerCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.
Rainer A LeitgebCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0131-4111

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo access to molecular information of retinal tissue is considered to play a critical role in enabling early diagnosis of ophthalmic and neurodegenerative diseases. The current gold standard of retina imaging, optical coherence tomography and angiography provides only the retinal morphology and blood perfusion, missing the full spectrum of molecular information. Raman spectroscopy addresses this gap while keeping the investigation non-invasive and label-free. Although previous studies have demonstrated the huge diagnostic potential of combining both modalities for in vivo biological tissue measurement, some have either employed unsafe optical power levels for in vivo retinal measurements or presented results that were negative or contradictory. In this study, we have developed an eye-safe multimodal in vivo label-free imaging system and demonstrate the potential of this device by investigating the retina of a living albino rat. The acquired Raman spectra showed relevant Raman bands in comparison with the previous ex vivo studies. Using this multimodal imaging system for non-invasive retina measurements of transgenic rodents holds the potential to advance the understanding of the pathophysiology of both ophthalmic and neurodegenerative diseases.

Identifiers

PMID39958836
PMCPMC11828446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.